Dr. Palanisamy Sivanandy is an eminent academician and researcher with more than 19 years
of teaching and research experience. He has more than 27 years of experience in the
pharmacy field. Currently, Dr Palanisamy has been working as a Programme Director at the
International Medical University, Kuala Lumpur, Malaysia since 2014.
He started his career as a Dispensing pharmacist in the year 1997 as a Diploma Pharmacist; in
2005 he completed his Pharmacy Under graduation (B.Pharm) from the Madurai Medical
College, Tamilnadu; in 2007 he obtained his Post Graduation (M.Pharm) in Pharmacy
Practice from Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamilnadu.
He completed his Ph.D., in the year 2013 from the prestigious Tamil Nadu Dr. MGR Medical
University, Chennai, and the Good Clinical Practice Licensure Exam from the Ministry of
Health (MoH), Malaysia in 2014.
He has published more than 100 research and review papers in various national and
internationally indexed peer-reviewed journals and has been serving as Chief editor and an
editorial board member of repute for more than 10 international journals.
He has received many grants from the Indian Council of Medical Research, New Delhi,
India; Department of Science & Technology, New Delhi, India; Centre for International Co-
Operation in Science, Chennai, India; and International Medical University, Kuala Lumpur,
Malaysia.
He has presented many research papers in conferences in various countries like Turkey, the
United States of America, South Korea, Singapore, Thailand, Indonesia, the Philippines,
India, and Malaysia.
Dr. Palanisamy has been awarded the “Outstanding Researcher in Pharmacology Award” in
2018, “Education Leadership Award” in 2019, “Global Knowledge Management Award” in
2020, “Dynamic Pharma Teacher Award” in 2020, “IMU Achievement Award” in 2020,
“AKS Global Faculty Award” in 2021, “Leadership in Community Service (Individual and
Group) Awards” in 2021, “Business Process Improvement Award” in 2021, “IMU SoP -
Book Chapters Award” in 2021, “Distinguished Professor Award” in 2021, “National
Education Excellence Achievers Award” in 2022, “Award of Leadership in Programme
Management”, in 2022, “Best Academician” award in 2022, “Award of Leadership in
Programme Management” in 2023, elected as the FELLOW of the Royal Society for Public
Health (FRSPH), UK, in August 2023, “Teaching Excellence Award” in 2024, and “IMU-
Long-Service Award in 2024, “Award of Leadership in Programme Management” in
2024,“Academic Board Member” by Global Open Share Publishing Pty Ltd, Alfredton,
Australia in 2025.His main areas of interest are Cardiovascular and diabetic medications, Oncology,
Pharmacovigilance, Drug Safety Monitoring, Prescription Auditing, Clinical Research and Development, Cerebrovascular complications and rehabilitation, Clinical Trials, Patient
Safety, Social and Administrative Pharmacy, and Falls risk medications.